Increasingly, AITD coexists with metabolic disorders such as obesity, insulin resistance, and metabolic dysfunction-associated steatotic liver disease (MASLD), suggesting an interplay between immune dysregulation and metabolic health
Depends on the state: Yes in Texas, Florida, California, Pennsylvania, Illinois (under current federal DEA extension through 2026) No in New York (in-person exam required for any controlled substance) Check state law for otherssome may have restrictions Even in states that allow it, you must conduct a thorough telehealth exam (live video), check the PDMP, and document clinical justification
Using ASCs to study lipedema provides insight into potential biomarkers, such as Bub1, that could be used to diagnose lipedema and serve as a therapeutic target to arrest pathological tissue growth
This is higher than the dose many patients take for diabetes, sometimes as low as 1.0 mg
Reduces melanin production, resulting in lighter and brighter skin
He F, Chen W, Xu W, et al